Wednesday, July 8, 2026

biotech · Bladder Cancer · Non Muscle Invasive Bladder Cancer · CGON

CG Oncology

CG Oncology trial registry — 9 ClinicalTrials.gov studies with program phase, status, and indication context.

Dallas, USA HQ
2010 Founded
187 Employees
Public company Type
CGON · NYSE Ticker
Company details
Status
Public
HQ
Dallas, USA
Founded
2010
Employees
187
Programs
8
Drugs
1
Patents
5
Intelligence · Clinical Trials

CG Oncology clinical trials

Registry index of 9 ClinicalTrials.gov studies linked to CG Oncology programs — each row shows trial ID, program name, phase, status, and indication.

CG Oncology trial registry — 9 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

8 updates

Latest clinical program signals indexed for CG Oncology.

  1. CG0070 Adenovirus Vector — Phase 3

    Clinical update
  2. Cretostimogene Grenadenorepvec — Phase 3

    Clinical update
  3. CG0070 — Phase 2

    Clinical update
  4. CG0070 — Phase 2

    Clinical update
  5. Cretostimogene Grenadenorepvec — Phase 2

    Clinical update
  6. Ivaltinostat — Phase 2

    Clinical update
  7. oncolytic adenovirus expressing GMCSF — Phase 2

    Clinical update
  8. CG0070 — Phase 1

    Clinical update

Trial registry

9 studies